Sarepta Sinks on Disappointing Gene-Therapy Study Results


Sarepta Therapeutics  (SRPT) – Get Report shares plunged on Friday, losing nearly half their value after a key gene-therapy study produced disappointing results.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *